Close

Blogs

An Inclusive Approach To Improve Global Access To Medicines

Health officials from nations around the globe are convening in Geneva to set the global health agenda for the coming year at the annual World Health Organization (WHO) Executive Board (EB) meeting. Several critical topics will be discussed at the upcoming meeting—non-communicable diseases, eradication of polio, and responding to disease outbreaks—but perhaps none is as […]

Read More

Setting The Stage For 2019: A Look Back At The UNGA 2018

Each year, world leaders gather in New York City for the United Nations General Assembly (UNGA) to engage in policymaking discussions, side events, and more. At the 2018 UNGA, all eyes were on two high-level meetings to address the impact of a couple of pressing global health issues – noncommunicable diseases (NCDs) and tuberculosis (TB). […]

Read More

Countdown to September: Innovation Critical to Efforts to Battle Global Health Crises

The clock is ticking ahead of two crucial United Nations high-level meetings slated for September in New York. These meetings are focused on two important health-related goals that rightfully demand global attention: ending tuberculosis and battling noncommunicable diseases. Yet, as member states work busily on draft outcomes for these meetings, they must promote strong incentives […]

Read More

Engage all stakeholders to address global nutrition issues

All member states and members of the global community agree that adequate nutrition is essential for positive public health outcomes and that all stakeholders must work together to improve public health. That is why the WHO’s goals to improve nutrition are above reproach – though, unfortunately, their tactics and programs are not. At a time […]

Read More

Combat Non-Communicable Diseases

Few causes garner as much support as the need to combat non-communicable diseases (NCDs). Ranging from obesity to diabetes to chronic respiratory disease, NCDs affect every nation and touch every person. Ending or curtailing many of these diseases will not only save governments money by reducing the cost of care, but will have an additive […]

Read More

Incentivize innovation and intellectual property

Similar to the WHO’s troubling actions on access to medicine, in January the WHO Executive Board (EB) revisited the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPOA), discussing a report from an unaccountable expert panel which included recommendations that would damage intellectual property rights. The existing GSPOA was negotiated […]

Read More

The Global Shortage of, and Access to, Medicines and Vaccines

In its January Executive Board meetings, WHO leadership and staff doubled down on its problematic approach to health innovation with the Director-General’s report on addressing the global shortage of, and access to, medicines and vaccines. The report and the meeting avoided a real discussion on health access in favor of a divisive, narrow attack on […]

Read More

Ahead of the World Health Assembly:

Ahead of the World Health Assembly: Next week, the 194-member states of the World Health Organization (WHO) will convene in Geneva for the 71st World Health Assembly (WHA), setting the WHO program of work for the coming year and holding critical discussions on global health. The EAGL Coalition supports the WHO’s vital mission in improving […]

Read More